The skin is a squamous epithelium that is continuously renewed by a 
Introduction
The YAP family of transcriptional co-activators are emerging as potent oncoproteins that strongly drive cell proliferation in many types of stem/progenitor cells and cancers Irvine and Harvey, 2015; Pan, 2010 Pan, , 2015 Piccolo et al., 2013) . The function of YAP family coactivators was first discovered by Drosophila genetics, where the sole YAP homologue -Yorkie (Yki) -was found to be necessary and sufficient to promote cell proliferation and tissue overgrowth in epithelia (Huang et al., 2005) . Subsequent genetic experiments in mice showed that ectopic expression of YAP was sufficient to drive cell proliferation in liver, intestine, bronchus and skin Camargo et al., 2007; Dong et al., 2007; Schlegelmilch et al., 2011; Zhang et al., 2011a; Zhao et al., 2014) . Surprisingly, YAP knockout mice were shown to have mild phenotypes, although they were deficient in proliferative repair of the intestine and resistant to intestinal tumour formation (Azzolin et al., 2014; Cai et al., 2010) as well as showing reduced bronchial stem cells (Zhao et al., 2014) and kidney defects (Reginensi et al., 2015) . An important and widespread physiological role for YAP in mice might be obscured by the possibility of redundancy between YAP and TAZ, a second mammalian family member that is highly similar in both sequence and function.
At the molecular level, Yki and YAP were shown to function by associating with the DNA-binding transcription factor Scalloped (Sd; or TEAD in humans) to drive transcription of anti-apoptotic and pro-proliferative target genes (Koontz et al., 2013; Liu-Chittenden et al., 2012; Vassilev et al., 2001; Wu et al., 2008) . Other co-factors of Yki/YAP that promote transcription include WBP2 (Zhang et al., 2011b) , MASK1/2 (Sansores- Garcia et al., 2013; Sidor et al., 2013) , and the SWI/SNF complex (Jin et al., 2013; Oh et al., 2013) . The activity of Yki was found to be regulated by the Drosophila Hippo-Warts (HpoWts) kinase signalling pathway, in which Wts directly phosphorylates Yki to promote its relocalisation from the nucleus to the cytoplasm (Dong et al., 2007; Huang et al., 2005; Oh and Irvine, 2008) . In human cells in culture, YAP nuclear localisation is similarly inhibited upon LATS1/2 kinase phosphorylation, Development • Advance article because phosphorylated YAP is retained the cytoplasm by binding to 14-3-3 family proteins (Dong et al., 2007; Zhao et al., 2007) . This entire molecular system is now referred to as the Hippo signalling pathway.
Much recent work has aimed to identify upstream regulators of Hippo signalling. A group of apically-localised proteins including Crumbs (Crb, CRB1/2/3 in humans), Merlin (Mer, NF2 in humans), Expanded (Ex, similar to Willin and AMOT in humans) and Kibra (Kib, KIBRA in humans) were found to activate Hippo signalling (repressing Yki activity) in Drosophila epithelia (Baumgartner et al., 2010; Chen et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006; Ling et al., 2010; Varelas et al., 2010; Yu et al., 2010) and in mice (Szymaniak et al., 2015) . In addition, a group of adherens junction-localised proteins including Ajuba, Zyxin, Dachs, Mib and Riq, were shown to inhibit Hippo signalling (activating Yki) in Drosophila epithelia Das Thakur et al., 2010; Degoutin et al., 2013; Gaspar et al., 2015; Mao et al., 2006; Rauskolb et al., 2011) . Finally, manipulation of the level of F-actin in Drosophila can also affect Hippo signalling, possibly via signalling through the Src kinase, which can promote Yki activation (Enomoto and Igaki, 2013; Fernandez et al., 2011; Fernandez et al., 2014; SansoresGarcia et al., 2011) . Human YAP and TAZ were subsequently found to act as F-actin responsive mechanosensors in cell culture (Aragona et al., 2013; Benham-Pyle et al., 2015; Dupont et al., 2011; Zhao et al., 2007) , but how their subcellular localisation is physiologically regulated in human epithelial tissues and cancers in vivo remains a fundamental unsolved problem.
Here we examine the physiological function and regulation of YAP and TAZ in mammalian epithelial tissues. We focus on stratified squamous epithelia, particularly the skin, and compare our findings with columnar epithelia, such as the intestine and bronchus. We propose that YAP and TAZ act as sensors of both apical and basal signals in vivo, and that this regulatory logic explains why these proteins become nuclear localised in basal stem/progenitor cells to promote cell proliferation and tissue renewal. Elevation of YAP and TAZ can then drive increased cell proliferation during wound healing or tumour formation.
Results
YAP and TAZ are expressed in both mouse and human skin, and regulate gene expression in basal layer stem/progenitor cells.
We began by characterising the expression and subcellular localisation of YAP and TAZ in both mouse and human skin. Both proteins were found to be expressed and nuclear localised in a subset of cells in the skin of the mouse embryo, neonate and adult. Nuclear localisation of YAP and TAZ was particularly prominent in basal layer cells of both interfollicular epidermis and the hair follicle ( Fig 1A) . Some nuclear localisation was also detected in the highly flattened squamous cells, consistent with results in cell culture where cell flattening induces nuclear accumulation of YAP and TAZ (Dupont et al., 2011) (Fig 1A) . Human YAP and TAZ show a similar pattern of subcellular localisation in sections of adult human skin (Fig 1B) . Basal layer cells feature nuclear YAP and TAZ, while differentiating daughters feature cytoplasmic YAP and TAZ (Fig 1B) . Again, some nuclear localisation is also detectable in highly flattened squamous cells that have terminally differentiated (Fig 1B) .
To confirm that YAP and TAZ are transcriptionally active in the skin, we sought to identify YAP-regulated genes by an RNA-sequencing (RNAseq) approach in human keratinocytes. mRNA was isolated from cells expressing activated YAP5SA or siRNAs against YAP and subjected to RNAseq and gene-set enrichment analysis (Fig 1C, S1 ). We find that the YAP-regulated gene sets included: the previously identified Hippo/YAP reactomes; cell cycle reactomes (such as E2F targets or CyclinE associated genes); cell growth reactomes (such as Myc, global translation regulators or regulation of ornithine decarboxylase); cancer signalling reactomes (such as EGFR-Ras signalling targets); and cancer microenvironment/metastasis reactomes (including regulators of cellular interactions with the extracellular matrix) ( Fig   S1) . We therefore analysed the expression of the corresponding cell cycle (CycE1, PCNA, E2F1); cell growth (RPTOR, ODC1, ADC); EGFR and Integrin signalling (CYR61, CTGF, AREG, Integrins 3,6, 1, 2, 4) regulators ( Fig   1D) . We find a striking restriction of these YAP targets to the basal layer of Development • Advance article the skin, indicating that YAP/TAZ transcriptional regulation is active exclusively in the basal stem/progenitor cell population (Fig 1D) .
YAP and TAZ are required for skin homeostasis
To examine the physiological role of YAP and TAZ, we generated double conditional knockout (dKO) mice with the skin-specific Keratin5-CreERT recombinase. Compared with control animals, the YAP/TAZ cKO mice showed a dramatic loss of hair in patches beginning 2 weeks after tamoxifen injection in adult mice, or causing complete blockade of hair growth in neonates treated with tamoxifen (Fig 2A,B) . Histological sections of the skin revealed expression and nuclear localisation of YAP and TAZ in control skin which is lost in the dKO tissue. Proliferation of basal layer cells, as marked by Ki67 staining, was clearly reduced in YAP/TAZ cKO skin (Fig 2A,B) , as was YAP target gene expression (Fig S2) . These phenotypes are reminiscent of skin-specific conditional knockouts of Integrin1 (ITGB1) (Brakebusch et al., 2000; Grose et al., 2002; Piwko-Czuchra et al., 2009; Raghavan et al., 2000; Singh et al., 2009 ).
We next tested whether YAP and TAZ contribute to skin repair after wounding.
We find that both YAP and TAZ levels become elevated after wounding, particularly in the basal cell layer of the epidermis where strong nuclear staining is visible (Fig 2C,D) . We next recorded the time taken to repair small (4mm) wounds in the back skin of control versus YAP/TAZ dKO mice. We find that control wounds normally heal completely by 10 days, while dKO wounds fail to heal within 10 days and instead require an additional 2 days to heal ( Fig   2E,F) . This delay in healing was not observed when YAP or TAZ were deleted individually. To investigate the cause of the delay in wound healing, we examined cell proliferation in control versus dKO wounds. We find that the number of Ki67-positive cells was reduced in dKO wounds versus controls (Fig 2G) . These findings demonstrate a crucial, physiological requirement for YAP and TAZ in basal layer stem/progenitor cells to promote cell proliferation.
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In the case of Integrin1 (ITGB1) conditional knockout skin, cells that escape Cre-mediated recombination are able to repopulate the mutant skin in a short timeframe (Piwko-Czuchra et al., 2009) . We find that the same phenomenon occurs in YAP/TAZ dKO skin, where after Cre activation and YAP/TAZ deletion, either YAP or TAZ positive residual cells expand in territory, consistent with the notion that YAP and TAZ promote proliferation of basal layer cells (Fig S3) . This phenomenon was also evident during wound healing, where YAP or TAZ positive cells were able to populate the wound and allow proliferation and healing in dKO animals ( Fig S3) . These findings underscore the importance of YAP and TAZ in epidermal progenitor cell proliferation and skin homeostasis and suggest a close relationship between Integrin signalling and YAP/TAZ function.
Mechanisms controlling YAP nuclear localisation in basal layer cells
We next sought to understand how YAP and TAZ become nuclear localised in basal layer cells. Since YAP and TAZ are similar proteins that localise identically in skin, we henceforth focus on regulation of YAP localisation.
Recent work in cultured MCF10A breast cancer cells indicated a role for Integrin-Src signalling and EGFR-PI3K signalling in promoting YAP nuclear localisation (Fan et al., 2013; Kim and Gumbiner, 2015) . To test whether these pathways are active in skin, we examined their expression and subcellular localisation. Mining the Human Protein Atlas dataset, we find that ITGB1, SRC, EGFR and AKT2 (a marker of PI3K activation) are all expressed strongly in basal layer cells, with AKT2 recruited to the interface between basal layer epidermal cells and the underlying basement membrane extracellular matrix (Fig 3A-E) . This pattern is also evident in other squamous epithelia such as cervix or oesophagus and is retained in squamous cell carcinomas (Fig 3A-E) . These data suggest that nuclear YAP localisation may be stimulated by Integrin-Src and/or PI3K signalling in basal layer skin keratinocytes ( Fig 3F) .
To confirm that Integrin-Src and PI3K signalling pathways are required for YAP nuclear localisation in keratinocytes, we systematically manipulated Development • Advance article these pathways with siRNA knockdown or treatment with specific inhibitor compounds in human keratinocytes in culture. We find that inhibition of Integrin1 (ITGB1) with blocking antibodies or siRNA, inhibition of the downstream effectors SRC or FAK, or inhibition of PI3K profoundly impairs YAP nuclear localisation (Fig 4A,B) . Interestingly, inhibition of the PI3K effectors AKT and TORC1 had no effect on YAP localisation, while inhibition of PDK1 did partially impair YAP nuclear localisation (Fig 4C) . Notably, drugs inhibiting F-actin, Myosin-II, or Rho-kinase had only a moderate effect on YAP localisation in keratinocytes (Fig 4D) . Quantification of these phenotypes highlights the strong effect of Integrin-Src and PI3K inhibition (Fig 4E) . Both Src inhibitors and PI3K inhibitors lead to a clear increase in phosphorylated YAP (p-YAP) indicating that Hippo signalling (MST-LATS signalling) is elevated by these treatments (Fig 4F) . We confirmed these findings in a classic 'scratch-wound' assay, where Src inhibition completley reversed the nuclear localisation of YAP at the leading edge ( Fig 4G) . These findings indicate that Integrin-Src and EGFR-PI3K signalling are essential for YAP nuclear localisation in keratinocytes ( Fig 4H) .
To extend these findings in vivo, we examined the role of Integrin-Src signalling in mouse skin. We compared YAP localisation in untreated and TPA-treated (inflamed) skin samples from control animals and knockouts for FAK or Src (Fig 5A-C) . We find that loss of FAK or Src results in decreased YAP levels and nuclear localisation in both normal and inflamed skin (Fig 5A-C ). Some nuclear YAP remained in flattened cells (Fig 5A-C asterix) . Similar results were obtained by treatment of mice with topical Src inhibitor (Dasatinib), which was able to drastically reduce YAP levels and nuclear localisation in untreated or TPA-treated skin, as well as in skin papillomas induced by a TPA+DMBA treatment regimen (Fig 5D-I ). These findings show that Integrin-Src signalling is crucial to promote YAP stabilisation and nuclear localisation in basal layer stem/progenitor cells. Accordingly, recent work indicates that skin papillomas induced by DMBA+TPA in mice can be strongly reduced in size and frequency by homozygous deletion of YAP along with one copy of TAZ, or by treatment with Dasatinib (Creedon and Brunton, 2012; Serrels et al., 2009; Zanconato et al., 2015) .
Mechanisms controlling YAP cytoplasmic localisation in differentiating daughter cells of squamous versus columnar epithelia
The above analysis suggests that daughter cells differentiate in the skin simply by loss of contact with the basement membrane extracellular matrix and consequent loss of Integrin-Src signalling, EGFR-PI3K signalling and YAP nuclear localisation. This model is plausible in all stratified squamous epithelia, but cannot explain the self-renewal versus differentiation decision in columnar epithelia -because differentiated columnar epithelial cells retain contact with the basement membrane. Thus, columnar cells must employ an additional mechanism to promote YAP localisation to the cytoplasm. An obvious candidate is the expression of a differentiated apical plasma membrane domain in columnar epithelial cells, because apical proteins associated with Crumbs (CRB3) are well known to induce Hippo signalling (MST-LATS signalling) to drive YAP to the cytoplasm (Chen et al., 2010; Fletcher et al., 2015; Ling et al., 2010; Szymaniak et al., 2015; Varelas et al., 2010) .
To test this notion in vivo, we compared the subcellular localisation of YAP with that of CRB3 in colunmar epithelia such as gallbladder, endometrium, lung bronchus, breast duct, urinary bladder, small intestine, colon and salivary gland. In all cases, apical localisation of CRB3 in differentiated daughter cells correlates with cytoplasmic localisation of YAP (Fig 6A-H) . Accordingly, basal layer stem/progenitor cells of the lung, breast or intestine retain nuclear YAP but lack apical CRB3. Notably, CRB3 is not expressed in squamous epithelia so cannot mediate the regulation of YAP in these tissues (Fig 6I-L) . The key Hippo pathway components MERLIN, SAV1 and KIBRA co-localise with CRB3 ( Fig S4, S5 ) (Chen et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006; Ling et al., 2010; Yin et al., 2013; Yu et al., 2010; Zhang et al., 2010) . These results indicate that a universal regulatory logic exists in which Development • Advance article YAP nuclear localisation requires contact with the basement membrane but is inhibited by expression of an apical domain ( Fig 6M) .
We next sought to confirm that apical and basal signal act antagonistically in colunmar epithelial cells. We examined human intestinal epithelial cells in culture that are capable of forming 3D cysts or 2D monolayers in which YAP becomes cytoplasmic. We find that siRNA knockdown of the apical determinant Cdc42 or LATS1/2 have similar effects, driving YAP to the nucleus (Fig 7A,B) . Strong YAP nuclear localisation can also be achieved simply by plating these cells at low density, so that they are unable to differentiate an apical domain and also retain a flat morphology with an extensive basal surface area (Fig 7C) . This basal contact appears to invoke the same Integrin-Src signals identified in keratinocytes, because blocking of Integrins with low Ca 2+ , anti-ITGB1 antibodies, or ITGB1 siRNAs relocalises YAP to the cytoplasm (Fig 7C) . Inhibition of Src, FAK, PI3K or PDK1 also impairs YAP nuclear localisation (Fig 7D,E) . These effects are once again as strong as inhibition of F-actin, Myosin-II or Rho-kinase (Fig 7F,G) .
Examination of phospho-YAP levels indicates that Integrin-Src signalling acts via regulation of MST-LATS phosphorylation of YAP (Fig 7H) . These results suggest that apical domain formation activates LATS kinases to retain YAP in the cytoplasm, while basal Integrin-Src and PI3K signalling inhibits LATS kinases to promote nuclear YAP localisation (Fig 7I) .
To further explore these findings in vivo, we examined how YAP behaves in columnar epithelial tumours that progress to invasive adenocarcinomas. We find that YAP remains cytoplasmic while tumours of the colon, stomach, lung, endometrium, urothelium or ovary retain their columnar epithelial form ( Fig   8A-F) . In contrast, invasive adenocarcinomas of the same tissue origin all feature a loss of columnar form and a dramatic localisation of YAP to the nucleus (Fig 8A-F) . These results suggest that loss of the apical domain during tumour progression allows YAP to become nuclear. We therefore tested whether nuclear YAP in invasive adenocarcinomas would be sensitive to inhibition of Integrin-Src signalling with Dasatinib. We examined Apc -/-P53 -/-mutant intestinal organoids that have been implanted subcutaneously into Development • Advance article nude mice. On transplantation these organoids rapidly produce highly invasive adenocarcinomas, entering the surrounding stromal tissue. We find that YAP localisation becomes strongly nuclear specifically in the invasive tumour cells (Fig 8G) . We next treated mice carrying such invasive tumours with the Src inhibitor Dasatinib, which strongly suppressed nuclear YAP localisation and reduced tumour growth and invasion (Fig 8H) . These findings indicate that Src activity promotes YAP nuclear localisation in vivo and suggest a potential therapy for invasive adenocarcinomas and carcinomas.
Discussion
Our results identify a physiological role for YAP and TAZ in skin homeostasis, (Fig 6&7, S4-S6 ) (Baumgartner et al., 2010; Chen et al., 2010; Fletcher et al., 2015; Genevet et al., 2010; Hamaratoglu et al., 2006; Ling et al., 2010; Sun et al., 2015; Szymaniak et al., 2015; Varelas et al., 2010; Yin et al., 2013; Yu et al., 2010) . The CRB3-MER-KIBRA-SAV complex appears to be absent in squamous epithelia, which never differentiate a true apical domain, leaving basement membrane contact as the sole regulatory mechanism (Fig 6) . Thus, our results show that antagonistic apical and basal polarity signals serve as the primary control mechanism that determines YAP subcellular localisation in vivo. In a striking parallel, the same apical and basal polarity determinants act antagonistically in epithelial membrane polarisation, with Integrin and PI3K signalling localising PtdIns(3,4,5)P3 basally, and helping to restrict and/or orient PtdIns(4,5)P2, Cdc42 and the CRB3 complex apically (Akhtar and Streuli, 2013; Bryant et al., 2014; Fletcher et al., 2012; Martin-Belmonte et al., 2007; Thompson, 2013) . Further work will be necessary to fully elaborate the molecular interactions that mediate the antagonistic relationship between apical and basal signals in cell polarisation and nuclear signalling via YAP.
This fundamental control mechanism appears to be conserved across the animal kingdom. For example, Drosophila simple columnar epithelia such as imaginal discs rely primarily on apical Crb-Mer/Ex-Kibra-Sav signalling to retain Yki in the cytoplasm and restrict tissue growth (Baumgartner et al., 2010; Chen et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006; Ling et al., 2010; Yu et al., 2010) . In contrast, Drosophila stratified columnar epithelia such as the intestine require Integrins, Src, EGFR, and Yki to Development • Advance article promote proliferation of basal layer stem/progenitor cells, suggesting that the regulatory connection between them described here may also be conserved (Cordero et al., 2014; Jiang et al., 2011; Kohlmaier et al., 2015; Lin et al., 2013; Shaw et al., 2010; Staley and Irvine, 2010; Xu et al., 2011) .
Furthermore, ectopic activation of Src, EGFR, PI3K or Yki in simple columnar imaginal discs is sufficient to induce overproliferation of cells, while loss of PI3K or Yki strongly impairs imaginal disc tumour formation (Doggett et al., 2011; Enomoto and Igaki, 2013; Fernandez et al., 2014; Herranz et al., 2012; Herranz et al., 2014; Strassburger et al., 2012; Willecke et al., 2011) .
Our model raises interesting questions about the possible physiological roles of other YAP regulators identified in cell culture, namely that YAP is controlled by Wnt signalling (Azzolin et al., 2014; Cai et al., 2015; Park et al., 2015) , GPCR signalling , PKA signalling , LKB1-MARK signalling (Mohseni et al., 2014) , Protease-activated receptors (Mo et al., 2012) , or the Mevalonate pathway (Sorrentino et al., 2014) . Importantly, our model is easily reconciled with a possible role of YAP as a mechanosensor in epithelial tissues in vivo (Dupont et al., 2011) . Mechanical force has been proposed to modulate signalling by both the apical CrbMer/Ex-Kibra-Sav system in Drosophila (Fletcher et al., 2015; Rauskolb et al., 2014) as well as the basal Integrin-Src system in mammalian cell culture (reviewed in (Humphrey et al., 2014; Lawson and Burridge, 2014) ). In the early mouse pre-implantation embryo, cortical tension is higher in outer cells than inner cells, leading to nuclear YAP in outer cells despite the presence of an apical domain (Anani et al., 2014; Kono et al., 2014; Nishioka et al., 2009 ).
Consistently, reducing cortical tension with ROCK inhibitor abolishes YAP nuclear localisation in early mouse embryos (Anani et al., 2014; Kono et al., 2014; Nishioka et al., 2009) . Mechanical forces may also explain why YAP becomes nuclear in some terminally differentiating and extremely flattened keratinocytes (Fig 5, cells marked by asterix) .
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Finally, our model is also easily reconciled with ability of YAP to respond to inflammatory cues in epithelia, such as Interleukin-6 (IL-6). Recent work revealed that the IL-6 co-receptor gp130 triggers stabilisation and nuclear translocation of YAP via Src kinases (Taniguchi et al., 2015) . This signalling module was shown to be activated by mucosal injury to intestinal epithelia to promote intestinal regeneration, a known Src and YAP function Cordero et al., 2014; Taniguchi et al., 2015) . We confirm that tissue damage (with 14Gy of radiation) elevates YAP levels in a Src-dependent manner in the intestine (Fig S7) . However, we note that upon damage YAP is still most nuclear in basal crypt stem cells, which normally lack an apical domain, and mostly cytoplasmic in differentiated columnar epithelial cells, which have an apical domain (Fig S7) . Interestingly, hyperproliferation per se driven by conditional deletion of APC and oncogenic mutation of KRAS (VillinCreER Apc fl/fl K-ras LSL-G12D ) does not change the fundamental pattern of YAP localisation, with YAP remaining most strongly nuclear in the basal stem cells but not the columnar epithelial cells (Fig S6) . In the skin, YAP is also elevated upon wounding (Fig 2C,D) or inflammation (upon TPA treatment) in a Src-dependent manner (Fig 5) , but remains most strongly nuclear in the basal layer stem/progenitor cell population (Fig 5) . Thus, Src acts as a point of convergence between inflammatory cues and apical-basal polarity cues, with polarity cues being the dominant input. Further work is necessary to understand whether Src acts primarily by directly phosphorylating YAP or indirectly via enhancing PI3K signalling to inhibit MST-LATS activity.
Nevertheless, our findings add weight to the notion that chemical inhibitors of
Src kinases such as Dasatinib are promising cancer therapeutics (Creedon and Brunton, 2012; Karim et al., 2013) (Fig 8) .
In conclusion, epithelial stem/progenitor cell proliferation and differentiation may be regulated primarily by apical-basal polarity signals. In particular, YAP, a key driver of cell proliferation in stem/progenitor cells and cancer, appears to act primarily as a sensor of epithelial cell polarity and only secondarily as a sensor of other stimuli. Stem/progenitor cells thus use information about their polarity status to inform their decisions to either proliferate or arrest/differentiate via control of YAP. In the skin epithelium, nuclear YAP acts redundantly with TAZ to drive gene expression in the basal stem/progenitor cell layer to maintain cell proliferation and normal tissue homeostasis.
Materials and Methods

siRNA treatment
Human Caco-2, A431 or HaCAT cells were cultured as previously stated (Fletcher et al., 2015 , Elbediwy et al., 2012 . All siRNA transfections were performed using Lipofectamine RNAiMax transfection reagent (invitrogen).
Briefly cells were seeded in 6 well plates and treated with the siRNA/transfection mix 2 hours post seeding. A final concentration of 50-100nM siRNA was used for transfections. The following day, another transfection was performed before the cells were trypsinised four hours later and reseeded either for 2D pr 3D culture. 2D siRNA treatments were left for a total of 72 hours, and 3D treatments were left for a total of 120 Hours. 3D cultures were prepared as previously stated (Elbediwy et al., 2012) . siRNA were used as siGenome pools (Dharmacon). confocal microscope using a 63x oil immersion objective, and processed using Adobe Photoshop. Fixation and cell culture quantification was carried out as previously described (Fletcher et al., 2015) 
Inhibitor, blocking antibody and low calcium media treatments
Mouse strains
All experiments were carried out in accordance with the United Kingdom and described previously (Marcotte et al., 2012; Ridgway et al., 2012) . Apc -/-P53 -/-(Apc 580D/580D P53 Trp53 2−10 allele) mice were obtained from Owen Sansom previously described (Jonkers et al., 2001; Shibata et al., 1997) .
AhCre is previously described (Ireland et al., 2004) . K-ras G12D allele is from Tyler Jacks (Jackson et al., 2001 ).
Yap/Taz conditional deletion
Tamoxifen (Sigma, 20mg/ml in peanut oil) was injected intraperitoneally ( 
Wound healing
Following the 5-day tamoxifen treatment, 4 hydroxy-tamoxifen (4OHT, sigma) was topically applied to shaved backskin for 5 consecutive days at a dosage of 10mg/ml in Ethanol and 100 µl was applied per mouse. Mice were anaesthetized with IsoFlo® (Isoflurane, Abbott Animal Health) and treated with the analgesics Vetergesic® (Alstoe Animal Health) and Rimadyl TM (Pfizer Animal Health) for x days after wounding. A 4 mm punch wound was made in the backskin using a biopsy punch (Miltex) 10 days after tamoxifen/4OHT treatment start and wound closure monitored over time.
Dasatinib treatment of skin
Wildtype mice between 8-12 weeks of age were topically treated with 150 µl Dasatinib (10 µM in DMSO, Selleck) onto the shaved backskin directly followed by 200 µl TPA (12-O-tetradecanoylphorbol-13-acetate; stock dissolved in DMSO and diluted in acetone, 12.5 µg/mouse) treatment for two consecutive days. Mice were analyzed and the backskin harvested on the third day. Control mice were treated with DMSO)/acetone.
Chemical carcinogenesis
Chemical skin carcinogenesis was induced on 12 week old v-Ha-Ras transgene (TG.AC)-expressing mice in mixed background by a single application of 100 µg/mouse DMBA (7,12-dimethylbenz(a)anthracene) onto the shaved backskin followed by biweekly topical treatments with TPA (4 µg/mouse) starting one week after DMBA application. Skin papillomas were detectable 8 weeks DMBA-TPA treatment start and harvested at 13 weeks.
For dasatinib treatment, papillomas allowed to reach an approximate size of ~1 cm 3 . These established papillomas were treated topically with dasatinib (10 µM in DMSO/acetone; 100 µl/papilloma) once and analyzed 3 or 7 days thereafter. For generation of skin carcinomas, ~12 week old DMBA-treated Development • Advance article FVB/N wildtype mice were treated biweekly with 4 µg/mouse TPA onto shaved backskin for 10 weeks then weekly for a further 4 weeks before the carcinomas were harvested.
Intestinal experiments
Mice carrying the AhCre recombinase were induced by 3 daily intraperitoneal (i.p.) injection of 80 mg/kg β-Napthoflavone for one day. Intestinal phenotypes were analyzed 4 or 7 days after transgene induction to assess homeostasis or regeneration, respectively. Intestinal regeneration was induced by irradiating mice with 14Gy gamma-irradiation four days after recombinase induction.
Mice were sacrificed 72h post irradiation and the small intestine isolated and flushed with tap water. 10x 1cm portions of small intestine were bound together with surgical tape and fixed in 4% neutral buffered formalin.
Organoid transplantation experiments
Intestinal crypts from VillinCreER Apcfl/fl P53fl/fl mice were removed 4 days following Cre induction with tamoxifen (2mg). This causes full recombination at both the APC and P53 loci and organoids now grow as sphere in an RSpondin independent manner (Sato et al., 2009 ). For transplantation of organoids, 50 organoids are transplanted subcutaneously into nude mice (see . For dasatanib treatment, a dose of 10mg/kg daily gavage was chosen as we have previously shown to cause a reduction in p-SRC in vivo without toxicity (Morton et al., 2010) . Mice were treated continuously from 10 days post injection of spheres.
Immunohistochemistry
Mouse backskin samples were harvested and fixed in neutral-buffered formaldehyde 10% vol/vol and then embedded in paraffin blocks. 4uM thick sections were cut deparrinifised and rehydrated using standard methods.
After an antigen retrieval step, sections were stained with Hematoxylin and Eosin (H&E) solution or with primary antibody. Additional images of human samples were obtained by data-mining the www.proteinatlas.org database (Berglund et al., 2008; Lundberg and Uhlen, 2010; Ponten et al., 2008; Uhlen et al., 2005; Uhlen et al., 2015; Uhlen et al., 2010) .
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RNAseq analysis
A431 or HaCAT cell lysates transfected with empty vector, YAP1 S5A,control siRNA or YAP1 siRNAs were used. Sequencing was performed on biological triplicates on the Illumina HiSeq 2500 platform and generated ~69 million 100 bp paired end reads per sample. Sequenced reads were trimmed to 75 base pairs and mapped to the Refseq genome model, using RSEM (version 1.2.21).
RSEM uses the bowtie2 alignment tool. Gene counts were filtered to remove genes with 10 or fewer mapped reads per sample. TMM (treated mean of Mvalues) normalisation and differential expression analysis using the negative binomial model was carried out with the R-Bioconductor package "EdgeR".
Genes with logCPM > 1 and FDR < 0.05 were judged to be differentially expressed. Enrichments of pathway-, category-and motif gene sets were assessed using GSEA with logFC pre-ranked gene lists. Gene sets with an enrichment false discovery rate (FDR) value of less than 0.05 were judged to be strongly statistically significant and values of less than 0.25 significant. (E) Imaging of wound healing in control (n=8) and YAP/TAZ double conditional knockout mice (dKO; n=8). Note delayed healing in dKO.
(F) Quantification of wound healing rates in control versus dKO animals.
ImageJ was used to measure the wound area at each stage. 
